ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,764Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 2116

$953K Total Retail Price of All Prescriptions

Rank: 156 out of 2116

346 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Jersey
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

15% of this provider’s 346 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
WARFARIN SODIUM 605 527 43 1 11
FUROSEMIDE 602 533 80 2 6
SIMVASTATIN 526 445 78 3 2
LEVOTHYROXINE SODIUM 432 357 65 4 4
AMLODIPINE BESYLATE 400 338 63 5 1
METOPROLOL TARTRATE 358 320 65 6 10
NAMENDA 350 345* 28 7 24
POTASSIUM CHLORIDE 321 306 47 8 25
DONEPEZIL HCL 306 269 43 9 22
QUETIAPINE FUMARATE 298 227 37 A 10 58
LISINOPRIL 274 214 37 11 7
CLOPIDOGREL 262 227 38 12 12
ALPRAZOLAM 242 192 38 B 13 14
DIOVAN 222 177 26 14 16
FAMOTIDINE* 220 159 34 15 36
JANUVIA 212 165 20 16 31
OMEPRAZOLE 209 170 43 17 5
GABAPENTIN 199 114 30 18 23
BUSPIRONE HCL 199 175 19 18 168
RISPERIDONE 184 80 17 A 20 60
ALBUTEROL SULFATE 183 167 44 21 105
LEVETIRACETAM 179 129 19 22 76
TAMSULOSIN HCL 174 126 29 23 27
OXYCODONE-ACETAMINOPHEN 174 121 34 S2 23 47
CARVEDILOL 169 125 29 25 21
MIRTAZAPINE 164 159* 29 26 45
LANTUS 161 123 30 27 79
SANTYL 156 125 24 28 108
LORAZEPAM 148 126 27 B 29 38
ATORVASTATIN CALCIUM 144 104 25 30 3
LEVOFLOXACIN 142 99 70 31 59
METFORMIN HCL 142 83 26 31 8
IPRATROPIUM-ALBUTEROL 142 120 14 31 90
CLONAZEPAM 130 110 14 B 34 57
CYMBALTA 124 <11 <11 35 49
PANTOPRAZOLE SODIUM 122 92 32 36 29
FINASTERIDE 118 101 15 37 96
ESCITALOPRAM OXALATE 118 113* 20 37 33
OLANZAPINE 117 100 19 A 39 112
PAROXETINE HCL 116 111* 12 40 78
CITALOPRAM HBR 111 59 15 41 56
DIVALPROEX SODIUM 108 61 14 42 72
LACTULOSE 107 72 25 43 77
DIGOX 103 98* 17 44 92
SERTRALINE HCL 101 83 17 45 28
HUMALOG 99 59 17 46 146
ENALAPRIL MALEATE 96 74 23 47 32
ATENOLOL 93 88* 13 48 26
CARBIDOPA-LEVODOPA 92 87* 13 49 113
PROCRIT 88 <11 <11 50 253
LOSARTAN POTASSIUM 87 87 12 51 15
ALLOPURINOL 86 81* 15 52 48
METOPROLOL SUCCINATE 85 68 15 53 9
MUPIROCIN* 75 52 21 54 130
FENOFIBRATE* 70 <11 <11 55 85
TRAMADOL HCL 68 44 16 56 30
NUEDEXTA 68 <11 <11 56 217
ZOLPIDEM TARTRATE 66 47 16 58 17
XARELTO 66 61* 11 58 173
ENOXAPARIN SODIUM 65 60* 15 60 184
NITROGLYCERIN PATCH 64 <11 <11 61 123
IBUPROFEN 64 31 17 61 74
NYSTATIN 63 46 26 63 149
LIDODERM 60 35 15 64 67
GLIMEPIRIDE 60 <11 <11 64 34
BENZTROPINE MESYLATE 59 <11 <11 R 66 159
NOVOLOG 58 46 17 67 127
OXYCODONE HCL 58 <11 <11 S2 67 61
CELEBREX 57 <11 <11 69 62
IPRATROPIUM BROMIDE 55 50* 11 70 201
LATANOPROST 55 <11 <11 70 154
ALENDRONATE SODIUM 54 40 12 72 39
AZITHROMYCIN 54 49* 43 72 35
KLOR-CON M20 54 54 14 72 116
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 41 31 75 175
CRESTOR 52 52 11 76 18
VALPROIC ACID* 52 <11 <11 76 204
DILTIAZEM HCL 51 <11 <11 78 282
DIVALPROEX SODIUM ER 51 <11 <11 78 178
CARBAMAZEPINE 51 <11 <11 78 213
PRANDIN 50 <11 <11 81 160
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.